Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dose Size and Dosing Frequency: Determination Methods01:21

Dose Size and Dosing Frequency: Determination Methods

Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...
Dose-Response Relationship: Selectivity and Specificity01:25

Dose-Response Relationship: Selectivity and Specificity

Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and β2-adrenergic receptors...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Therapeutic Hybrid Intelligence with Neural and Knowledge-based Expert Reasoning for SRS (THINKERS): an AI model for GBM.

Journal of neuro-oncology·2026
Same author

Dose De-escalation in Stereotactic Radiosurgery for Melanoma Brain Metastases in Patients on Concurrent Immunotherapy or Targeted Therapy: A Multicenter Experience.

Neurosurgery·2026
Same author

Beyond tumor control: symptom trajectories and hearing outcomes after contemporary Gamma Knife radiosurgery for vestibular schwannoma.

Journal of neuro-oncology·2026
Same author

Therapeutic Hybrid Intelligence with Neural and Knowledge-based Expert Reasoning for SRS (THINKERS): a mixture-of-experts AI model for vestibular schwannoma.

Journal of neuro-oncology·2026
Same author

Volume-Staged Stereotactic Radiosurgery in Pediatric Patients With Large Brain Arteriovenous Malformations: An International, Multicenter Study.

Neurosurgery·2026
Same author

Role of radiosurgical thalamotomy in the management for essential tremor: evidence from an international multi-institutional study.

Journal of neurology·2026

Related Experiment Video

Updated: May 15, 2026

Stereotactic Radiosurgery for Gynecologic Cancer
10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

Dose selection in stereotactic radiosurgery.

John C Flickinger1, Hideyuki Kano, Ajay Niranjan

  • 1Department of Radiation Oncology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15232, USA. flickingerjc@upmc.edu

Progress in Neurological Surgery
|December 22, 2012
PubMed
Summary
This summary is machine-generated.

Selecting the right radiation dose for arteriovenous malformation (AVM) radiosurgery balances obliteration success with minimizing complication risks. This review covers principles and data for guiding AVM radiosurgery dose selection.

More Related Videos

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Related Experiment Videos

Last Updated: May 15, 2026

Stereotactic Radiosurgery for Gynecologic Cancer
10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Area of Science:

  • Neurosurgery
  • Radiation Oncology
  • Medical Physics

Background:

  • Arteriovenous malformation (AVM) radiosurgery requires careful dose selection to balance treatment efficacy and patient safety.
  • The prescription dose is critical for achieving AVM obliteration while minimizing risks of radiation-induced complications.
  • Predicting individual patient complication risks is challenging, influenced by treatment volume, location, and tissue characteristics.

Purpose of the Study:

  • To review the principles and data that guide the selection of prescription doses in AVM radiosurgery.
  • To provide a framework for physicians to optimize dose selection in AVM radiosurgery treatment planning.

Main Methods:

  • Review of existing literature and clinical data on AVM radiosurgery outcomes.
  • Analysis of factors influencing complication risks, including treatment volume, target location, and tissue type.
  • Synthesis of principles for balancing obliteration rates and complication avoidance.

Main Results:

  • Dose selection involves a trade-off between achieving high obliteration rates and limiting potential adverse effects.
  • Factors such as AVM size, location within the brain, and surrounding critical structures significantly impact complication risk.
  • Understanding dose-volume relationships and radiobiological principles is essential for informed decision-making.

Conclusions:

  • Optimal AVM radiosurgery dose selection requires a personalized approach based on patient-specific factors and treatment parameters.
  • This review synthesizes current knowledge to aid clinicians in making informed decisions regarding prescription doses for AVM radiosurgery.
  • Further research may refine predictive models for complication risks to enhance treatment personalization.